M
Moon Surgical
Moon Surgical, formerly kown as MastOR, aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics
About Moon Surgical
Moon Surgical is a French company that has developed the Maestro System, a surgical robotic assistant designed for soft tissue surgeries. The system is not a fully autonomous robot but rather a collaborative tool that assists surgeons during laparoscopic procedures. It features two robotic arms that can hold and manipulate instruments, providing stability and freeing up the surgeon's hands. This allows for greater control and precision during operations.
Read full description
The Maestro System is designed to be adaptable and compatible with existing surgical instruments and workflows. The business model appears to be focused on selling the Maestro System to hospitals and surgical centers. The target clients are surgeons who perform laparoscopic procedures. The market is the broad laparoscopy market, which includes a high volume of annual soft-tissue surgeries currently underserved by telerobotic systems.
The company has received FDA clearance for its commercial Maestro Robotic Surgery System, which will support its commercialization efforts in the United States and Europe. The system also has Wi-Fi and 5G connectivity, enabling data exchange with Maestro Insights, a cloud-based platform, suggesting a potential for a data-as-a-service component to their business model in the future.
At a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Paris, France
- Employees
- 111
- Open positions
- None listed
- Dealroom signal
- 75.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Core AI, Immersive Technologies, Spinout, Medical Robots, Surgical Equipment
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Augmented Reality
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | May 2023 | $55M | $222M | Fred Moll · MD Start Accelerator · GT Healthcare · Yann Fleureau | ↗ |
| SERIES AOther financing | Jun 2022 | $31M | $125M | Johnson & Johnson Innovation · Yann Fleureau · GT Healthcare · Sofinnova Partners | ↗ |
Growth signals
Latest recorded traffic for Moon Surgical is 4.8K monthly website visits, down 5.9% over the last three months. Moon Surgical's team grew 11% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Series A11 investors entered at this stage
GT Healthcare
Johnson & Johnson Innovation
Yann Fleureau
Siddarth Satish- SLSacha Loiseau
- RLRichard Leparmentier
Fred Moll
MD Start Accelerator
Cathay Capital
Josh Makower
NVentures
Other known investors4 additional known investors
CNRS Innovation
French National Centre for Scientific Research - CNRS
SATT LUTECH
Sorbonne University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Moon Surgical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Moon Surgical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.